ANA Investigates Central Nervous System Tumor Classification
Release Date: 08/16/2021
ANA Investigates Vector-Borne Illness
ANA Investigates
Climate change is no longer a distant worry—it’s showing up in neurology clinics across the US, from Lyme meningitis in the Midwest to worsening migraines during heat waves, climate-linked and vector-borne neurological conditions are entering the differential. Our guests today are two experts on climate change and neurological health: Dr. Beth Malow, Professor of Neurology and Pediatrics at Vanderbilt University Medical Center, and Dr. Monica Diaz, Assistant Professor of Neurology at the University of North Carolina at Chapel Hill. They’ll explore the clinical impact of climate change on...
info_outline
ANA Investigates RLS
ANA Investigates
Restless leg syndrome is a common movement and sleep disorder affecting 2-3% of the population. Certain neurologic disorders are associated with a higher incidence, and neuropsychiatric medications prescribed by neurologists and psychiatrists often exacerbate these symptoms. In January, the American Academy of Sleep Medicine published updated guidelines for the evaluation and treatment of RLS. The recommendations shifted from recommending the use of dopamine agonists, to prioritizing iron evaluation and supplementation, alpha-2-delta ligands (gabapentin, gabapentin enacarbil, pregabalin),...
info_outline
ANA Investigates The Neural Exposome
ANA Investigates
Look around you right now and think for a minute about all of the things you’re exposed to: the coffee you’re drinking, the mug holding the coffee you’re drinking, the soap that mug was washed in, the sleep you got last night -- or didn’t get. All of this is part of what we now call your exposome. And as we’re learning, the neural exposome influences our risk of developing a range of neurologic diseases. Our guest today is Dr. Eva Feldman, the James W Albers Distinguished University Professor and the Russell N. De Young professor of neurology and neurosurgery at the...
info_outline
ANA Investigates Health Policy and Advocacy in Neurology
ANA Investigates
Neurologists bring an important perspective to health policy. But few have formal training in how to advocate for patients at a state or national level. Our guest today, Dr. Kara Stavros, is an associate professor of neurology at The Warren Alpert Medical School of Brown University and the President of the Rhode Island Medical Society. She’s also a self-described advocate, who’s found a number of ways to speak up for her patients and influence health policy. Dr. Stavros spoke about her path to advocacy with Dr. Sarah Nelson, Assistant Professor of Neurology at Tufts Medical Center. ...
info_outline
ANA Investigates Biological Staging of Parkinson’s Disease
ANA Investigates
Parkinson’s Disease has long been a clinical diagnosis. But recently, there have been proposals to redefine the disease based on biomarkers of alpha-synucleinopathy and dopaminergic dysfunction. A similar shift has already occurred in Alzheimer disease, with the “amyloid, tau, and neurodegeneration,” or ATN, classification system. Our guest today, Michael Okun, is is Professor of Neurology and Director of the Norman Fixel Institute for Neurological Diseases at the University of Florida and medical advisor for the Parkinson's Foundation. He co-authored an op-ed in...
info_outline
ANA Investigates Atrial Fibrillation After Stroke
ANA Investigates
We all know that atrial fibrillation is associated with increased risk of stroke. But new research suggests that how we define afib -- and the timing and duration of the arrhythmia -- may be important for how we manage it in stroke patients. Luciano Sposato is a Professor of Neurology and Head of the Stroke Program at Western University in Ontario. He’ll talk to Christoph Stretz, vascular neurologist at Brown University, about the latest research into afib and aflutter after stroke -- and how this research might impact current clinical practice. Series 6, Episode 4 Featuring: Guest: Dr....
info_outline
ANA Investigates Dementia in Africa
ANA Investigates
Dementia is a global issue, with two-thirds of people with dementia living in low- and middle- income countries. Despite this, dementia research continues to focus on patients in high-income countries. Our guest on this episode, Dr. Riadh Gouider, is working to correct this imbalance. Dr. Gouider is the Head of the Department of Neurology and the Alzheimer Center at Razi Hospital in Tunisia and an advisor on the latest WHO Global Action Plan on the public health response to dementia. He spoke with Dr. Jayant Acharya, Professor and Chair of Neurology at Southern Illinois University School of...
info_outline
ANA Investigates Minimally Invasive Surgical Treatments in Epilepsy
ANA Investigates
It used to be that surgery for medically refractory epilepsy was big, open and invasive, a treatment of last resort. The landscape has changed in recent decades, with more and more minimally invasive surgical approaches being developed. So what does this mean for the average patient with medically refractory epilepsy? Our guest today is Dr. Jon Willie, Associate Professor, Department of Neurological Surgery, Washington University School of Medicine in St. Louis. He speaks with Dr. Ionnis Karakis, Epileptologist and Adjunct Professor of Neurology at Emory University, about the new landscape of...
info_outline
ANA Investigates the Glymphatic System & Neurodegenerative Diseases
ANA Investigates
Until recently, the Glymphatic System was a neglected corner of neuroscience. Now it’s increasingly clear that the brain’s system for the flow of fluid, nutrients, and waste plays an important role in sleep and brain disease. With glymphatics in the spotlight, researchers are coming up with innovative ways to study this slow, constant flow of cerebrospinal fluid throughout the brain. Dr. Daniel Claassen is a Professor of Neurology and Chief of the Behavioral and Cognitive Neurology Division at Vanderbilt University, who researches the glymphatic system in humans. He’ll talk about new...
info_outline
**Bonus Episode** ANA Investigates ANA2024
ANA Investigates
Just last week, we wrapped up another exciting annual meeting of the American Neurological Association, ANA2024. Right before we packed up to head home, the President of the American Neurological Association, Dr. Betsy Ross, sat down with Dr. Allison Willis, the 2024 chair of the ANA’s Annual Meeting Programming Committee, to reflect on some of the highlights of this year's meeting. Series 5, Episode 12 Featuring: Guest: Dr. Allison Willis, the 2024 chair of the ANA’s Annual Meeting Programming Committee Interviewer: Dr. Betsy Ross, President of the American Neurological Association -...
info_outlineIn July, the World Health Organization released its updated classification of Tumors of the Central Nervous System. The last update was in 2016. The update reflects the increasing role of molecular biomarkers in tumor characterization -- a change that has major implications for how we diagnose and treat patients with brain and spinal cord tumors.
Joining us today to help us understand these changes is Dr. Lynne Taylor. Dr. Taylor is a professor of Neurology and Oncology at the University of Washington and co-director of the Alvord Brain Tumor Center at University of Washington Medical Center. Dr. Taylor was interviewed by ANA Investigates producer and neuro-oncologist, Dr. Doug Ney. Series 2, Episode #10